Table 4.
Non-masker | 8ms masker | 16ms masker | 64ms masker | |||||
---|---|---|---|---|---|---|---|---|
Wave V | CCT | Wave V | CCT | Wave V | CCT | Wave V | CCT | |
N = 27 | N = 27 | N = 20 | N = 19 | N = 21 | N = 21 | N = 27 | N =26 | |
Vinclozolin (ng/mL) |
0.14 (− 0.01 – 0.28)† |
0.12 (− 0.03 – 0.28) |
0.20 (0.05 – 0.36)* |
0.18 (0.01 – 0.35)* |
0.14 (− 0.07 – 0.36) |
0.12 (− 0.10 – 0.35) |
0.10 (− 0.08 – 0.29) |
0.15 (0.00 – 0.30)† |
Diethyltoluamide (ng/mL) |
0.23 (− 0.01 – 0.48)† |
0.24 (− 0.02 – 0.49)† |
0.24 (0.00 – 0.48)† |
0.21 (− 0.05 – 0.48) |
0.35 (0.04 – 0.67)* |
0.42 (0.11 – 0.73)** |
0.34 (0.04 – 0.63)* |
0.26 (0.01 – 0.51)* |
p < 0.01,
p < 0.05,
p < 0.10
N’s vary based on availability of useable ABR data.